These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38815138)

  • 21. Amelanotic melanoma: the great masquerader.
    Koch SE; Lange JR
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):731-4. PubMed ID: 10775846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.
    Vitiello M; Tuccoli A; D'Aurizio R; Sarti S; Giannecchini L; Lubrano S; Marranci A; Evangelista M; Peppicelli S; Ippolito C; Barravecchia I; Guzzolino E; Montagnani V; Gowen M; Mercoledi E; Mercatanti A; Comelli L; Gurrieri S; Wu LW; Ope O; Flaherty K; Boland GM; Hammond MR; Kwong L; Chiariello M; Stecca B; Zhang G; Salvetti A; Angeloni D; Pitto L; Calorini L; Chiorino G; Pellegrini M; Herlyn M; Osman I; Poliseno L
    Oncotarget; 2017 Apr; 8(15):25395-25417. PubMed ID: 28445987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.
    McClain SE; Mayo KB; Shada AL; Smolkin ME; Patterson JW; Slingluff CL
    Int J Dermatol; 2012 Apr; 51(4):420-6. PubMed ID: 22435430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a CD8+ T cells-related prognostic risk model for acral melanoma based on single-cell and bulk RNA sequencing.
    Wang W; Liu P; Ma J; Li J; Leng L
    Skin Res Technol; 2024 Aug; 30(8):e13900. PubMed ID: 39093712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelanotic malignant melanomas of the oral mucosa.
    Notani K; Shindoh M; Yamazaki Y; Nakamura H; Watanabe M; Kogoh T; Ferguson MM; Fukuda H
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):195-200. PubMed ID: 12054708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features, delayed diagnosis, and survival in amelanotic acral melanoma: A comparative study with pigmented melanoma.
    Wu Q; Pan J; Lin W; Zhao S; Chen M; Lu L; Chen X; Su J
    J Am Acad Dermatol; 2024 Feb; 90(2):369-372. PubMed ID: 37690705
    [No Abstract]   [Full Text] [Related]  

  • 27. Spatial transcriptomic analysis of tumour-immune cell interactions in melanoma arising from congenital melanocytic nevus.
    Lim Y; Cho BK; Kang SJ; Jeong S; Kim HJ; Baek J; Moon JH; Lee C; Park CS; Mun JH; Won CH; Park CG
    J Eur Acad Dermatol Venereol; 2024 Aug; 38(8):1599-1605. PubMed ID: 38420727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of novel melanoma cell lines.
    Zanna P; Maida I; Turpin Sevilla MC; Susca FC; Filotico R; Arciuli M; Cassano N; Vena GA; Cicero R; Guida G
    J Biol Regul Homeost Agents; 2011; 25(2):239-47. PubMed ID: 21880213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive appearance of pigmentation in amelanotic melanoma lesions.
    Cohen-Solal KA; Crespo-Carbone SM; Namkoong J; Mackason KR; Roberts KG; Reuhl KR; Chen S
    Pigment Cell Res; 2002 Aug; 15(4):282-9. PubMed ID: 12100494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma.
    Zhang C; Shen H; Yang T; Li T; Liu X; Wang J; Liao Z; Wei J; Lu J; Liu H; Xiang L; Yang Y; Yang M; Wang D; Li Y; Xing R; Teng S; Zhao J; Yang Y; Zhao G; Chen K; Li X; Yang J
    Nat Commun; 2022 Nov; 13(1):7250. PubMed ID: 36433984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma.
    Liao L; Han W; Shen Y; Shen G
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):362. PubMed ID: 39052109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
    Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
    J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.
    Wehbe M; Soudja SM; Mas A; Chasson L; Guinamard R; de Tenbossche CP; Verdeil G; Van den Eynde B; Schmitt-Verhulst AM
    PLoS One; 2012; 7(11):e49419. PubMed ID: 23173060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermoscopy for the Identification of Amelanotic Acral Melanoma.
    Koblinski JE; Ahrns HT; Morse MJ; Seiverling EV
    J Am Podiatr Med Assoc; 2022 Mar; 112(1):. PubMed ID: 36459055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
    Gui J; Guo Z; Wu D
    J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjunctival amelanotic malignant melanoma arising in primary acquired melanosis sine pigmento.
    Jay V; Font RL
    Ophthalmology; 1998 Jan; 105(1):191-4. PubMed ID: 9442798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
    Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
    J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polypoid amelanotic melanoma: a diagnostic challenge.
    Milani-Nejad N; Scarbrough C; Mauzo SH; Peters SB; Bechtel MA; Carr D
    Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to prove the melanoma origin in amelanotic human melanoma cell lines.
    Blasko M; Chalupa I; Borovanský J; Toceková M; Siracký J
    Neoplasma; 1996; 43(6):411-5. PubMed ID: 8996567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
    Thielmann CM; Chorti E; Matull J; Murali R; Zaremba A; Lodde G; Jansen P; Richter L; Kretz J; Möller I; Sucker A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Paschen A; Livingstone E; Zimmer L; Schadendorf D; Hadaschik E; Ugurel S; Griewank KG
    Eur J Cancer; 2021 Dec; 159():113-124. PubMed ID: 34742158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.